Related Experiment Video
Updated: Aug 23, 2026
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza immunisation in children: good for everyone or reserve for the chosen few?
Jeff Williams1, Patricia Goodwin
1Glan Clwyd District General Hospital, Rhyl, Denbighshire LL18 5UJ, UK. DrJeff.Williams@cd-tr.wales.nhs.uk
Insights
Influenza vaccination is crucial for children, but uptake is low due to data gaps. More evidence is needed to identify at-risk children and support routine immunization for better influenza prevention.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- Influenza infection causes significant childhood morbidity, yet precise epidemiological data on burden, severity, and complications in healthy children are lacking.
- Effective influenza vaccines exist, with intranasal live attenuated vaccines anticipated soon. Contraindications like egg allergy or short corticosteroid courses are less restrictive now.
Purpose of the Study:
- To address the lack of epidemiological data regarding influenza's impact on children.
- To evaluate the current status of influenza vaccination in children and identify challenges to uptake.
- To inform the development of evidence-based protocols for pediatric influenza immunization.
Main Methods:
- Review of existing epidemiological data on childhood influenza.
- Analysis of current vaccination guidelines and uptake rates.
- Identification of challenges and future research needs for pediatric influenza immunization.
Main Results:
- Significant morbidity from influenza in children is acknowledged, but precise data on burden and complications are insufficient.
- Current influenza vaccine uptake in targeted pediatric groups in the UK and elsewhere is low.
- Key challenges include defining which children benefit most and gathering evidence for routine immunization of healthy children.
Conclusions:
- Further research is essential to precisely define the benefits of influenza immunization for specific pediatric groups.
- More persuasive evidence is required to support the routine immunization of all healthy children against influenza.
- An evidence-based protocol is needed to build confidence among healthcare providers and parents regarding the importance, efficacy, and safety of pediatric influenza vaccination.
Abstract:
Influenza infection leads to significant morbidity in children. There is a lack of sound epidemiological data to define precisely the true burden, severity and rate of complications in otherwise normal children. Effective and safe vaccines are available with the prospect of an intranasally administered live attenuated vaccine being licensed in the near future. There are few contraindications to immunisation and, for children who will benefit from the procedure, short courses of oral corticosteroids and confirmed allergy to egg can no longer be regarded as such. The uptake of immunisation in the UK and other countries in categories of children defined and targeted by the Department of Health is currently low. A number of challenges remain. Firstly, to define more precisely which children will most benefit from immunisation and, secondly, to gather much more persuasive evidence if routine immunisation of healthy children is to be contemplated. Once these strands of evidence have been pulled together we need a clear evidence-based protocol which will reassure doctors and parents of the importance, efficacy and safety of influenza immunisation in whichever group of children have been identified as appropriate recipients.
Related Concept Videos
01:51Vaccinations
01:27Influenza
01:29Respiratory Syncytial Virus Disease
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:24Smallpox
01:21Vaccines